Literature DB >> 28777158

Pneumonia with bacterial and viral coinfection.

Kelly Cawcutt1, Andre C Kalil.   

Abstract

PURPOSE OF REVIEW: We aim to review the epidemiology of pneumonia with bacterial and viral coinfection, the pathogenesis and clinical impact of coinfection along with the current state of treatment and outcomes. RECENT
FINDINGS: Emphasis is given to the pathogenesis of bacterial and viral co-infection including specific highlighting on influenza, rhinovirus, respiratory syncytial virus and cytomegalovirus. Updates on the current state of diagnosis and management are included, as well as on areas where future research can be directed to improve patient clinical outcomes regarding viral and bacterial coinfection.
SUMMARY: Bacterial and viral coinfection is increasingly recognized as an underlying etiology for community- and hospital-acquired infections. Coinfections may be a risk factor for ICU admission, severity of disease, and mortality. Clinicians must be aware of these coinfections for appropriate management and prognostication, as well as for the prevention of nosocomial spread of viral illness.

Entities:  

Mesh:

Year:  2017        PMID: 28777158     DOI: 10.1097/MCC.0000000000000435

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  33 in total

1.  Low prevalence of community-acquired influenza coinfections among COVID-19 patients in Al-Madinah, Saudi Arabia: A retrospective cohort study.

Authors:  Sari T Alhoufie; Khalid O Alfarouk; Hatim M Makhdoom; Nadir A Ibrahim
Journal:  J Infect Public Health       Date:  2022-06-11       Impact factor: 7.537

2.  Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.

Authors:  Amanda P Smith; Evan P Williams; Taylor R Plunkett; Muneeswaran Selvaraj; Lindey C Lane; Lillian Zalduondo; Yi Xue; Peter Vogel; Rudragouda Channappanavar; Colleen B Jonsson; Amber M Smith
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

3.  Comparative Analysis of Early-Stage Clinical Features Between COVID-19 and Influenza A H1N1 Virus Pneumonia.

Authors:  Changxing Shen; Min Tan; Xiaolian Song; Guoliang Zhang; Jiren Liang; Hong Yu; Changhui Wang
Journal:  Front Public Health       Date:  2020-05-15

4.  Anemoside B4 protects against Klebsiella pneumoniae- and influenza virus FM1-induced pneumonia via the TLR4/Myd88 signaling pathway in mice.

Authors:  Jia He; Renyikun Yuan; Xiaolan Cui; Yushun Cui; Shan Han; Qin-Qin Wang; Yangling Chen; Liting Huang; Shilin Yang; Qiongming Xu; Yonghui Zhao; Hongwei Gao
Journal:  Chin Med       Date:  2020-07-02       Impact factor: 5.455

5.  2018 recommendations for the management of community acquired pneumonia.

Authors:  Ricardo de Amorim Corrêa; Andre Nathan Costa; Fernando Lundgren; Lessandra Michelin; Mara Rúbia Figueiredo; Marcelo Holanda; Mauro Gomes; Paulo José Zimermann Teixeira; Ricardo Martins; Rodney Silva; Rodrigo Abensur Athanazio; Rosemeri Maurici da Silva; Mônica Corso Pereira
Journal:  J Bras Pneumol       Date:  2018 Sep-Oct       Impact factor: 2.624

6.  Influenza and associated co-infections in critically ill immunosuppressed patients.

Authors:  Ignacio Martin-Loeches; Virginie Lemiale; Pierce Geoghegan; Mary Aisling McMahon; Peter Pickkers; Marcio Soares; Anders Perner; Tine Sylvest Meyhoff; Ramin Brandt Bukan; Jordi Rello; Philippe R Bauer; Andry van de Louw; Fabio Silvio Taccone; Jorge Salluh; Pleun Hemelaar; Peter Schellongowski; Katerina Rusinova; Nicolas Terzi; Sangeeta Mehta; Massimo Antonelli; Achille Kouatchet; Pål Klepstad; Miia Valkonen; Precious Pearl Landburg; Andreas Barratt-Due; Fabrice Bruneel; Frédéric Pène; Victoria Metaxa; Anne Sophie Moreau; Virginie Souppart; Gaston Burghi; Christophe Girault; Ulysses V A Silva; Luca Montini; Francois Barbier; Lene B Nielsen; Benjamin Gaborit; Djamel Mokart; Sylvie Chevret; Elie Azoulay
Journal:  Crit Care       Date:  2019-05-02       Impact factor: 9.097

7.  Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Respir Med       Date:  2018-12-12       Impact factor: 30.700

8.  Application of Optimal Control to Influenza Pneumonia Coinfection with Antiviral Resistance.

Authors:  Caroline W Kanyiri; Livingstone Luboobi; Mark Kimathi
Journal:  Comput Math Methods Med       Date:  2020-03-10       Impact factor: 2.238

Review 9.  Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus.

Authors:  Gaspar A Pacheco; Nicolás M S Gálvez; Jorge A Soto; Catalina A Andrade; Alexis M Kalergis
Journal:  Microorganisms       Date:  2021-06-13

10.  Epidemiology Characteristics of Streptococcus pneumoniae From Children With Pneumonia in Shanghai: A Retrospective Study.

Authors:  Wantong Zhao; Fen Pan; Bingjie Wang; Chun Wang; Yan Sun; Tiandong Zhang; Yingying Shi; Hong Zhang
Journal:  Front Cell Infect Microbiol       Date:  2019-07-18       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.